Boiler Explosion Lawsuit Results in $47M Settlement

A group of wrongful death, personal injury and property damage lawsuits filed over a fatal boiler explosion two years ago in St. Louis have been settled, but concerns persist in the area about the risk of similar incidents that may result from poor maintenance and inadequate inspections.

The boiler explosion occurred in April 2017, at the Loy-Lange plant in St. Louis. The blast fired the one-ton boiler through the facility’s roof, sending it smashing down into a laundry business, killing four and injuring three others.

Those killed included Kenneth Trentham, who died in the plant, and Clifford Lee, Christopher Watkins and Tonya Gonzalez-Suarez, who were killed when the boiler crashed into Faultless Healthcare Linen nearby. Those at the linen company were starting their first day on the job.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The incident resulted in four wrongful death lawsuits, three personal injury lawsuits and two property damage claims against Kickham Boiler and Engineering, Chicago Boiler Company, Aquacomp Water Treatment Services, Loy-Lange, and Arise, Incorporated.

Plaintiffs alleged that the manufacturers failed to include corrosion allowance on the pressure vessel, and that owners failed to do proper water chemistry treatment, sediment removal and inspections. Another company also failed to repair the boiler sufficiently and remove corroded materials from inside several years earlier.

According to a local media report by KSDK.com, the boiler explosion settlement resolves all of the outstanding cases, and resulted in the manufacturers paying $21 million, inspection consultants Arise Incorporated paying $17.5 million, and Loy Lange paying $4 million. The company that was supposed to repair the boiler will pay $728,000. The agreement comes out of mediation meetings in June.

Despite settlement of the lawsuit, the case has still left concerns in the St. Louis area after local media produced stories, sometimes involving anonymous inspectors, who say the city is failing at doing proper boiler inspections and maintenance, and that such incidents were inevitable.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted 2 days ago)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 3 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 4 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.